Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDE5A | O76074 | 4/20 | 0.34 |
| ▸ | PDE3B | Q13370 | 1/20 | 0.34 |
| ▸ | PDE3A | Q14432 | 1/20 | 0.34 |
| ▸ | PARP1 | P09874 | 1/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.30 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.30 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9636327 | 0.88 | PDE5A (0.37) | PDE5APDE3BPDE3APARP1 | |
| SCHEMBL10733507 | 0.87 | PDE5A (0.38) | PDE5APDE3BPDE3ALMNASMN1; SMN2 | |
| SCHEMBL10742305 | 0.83 | PDE5A (0.47) | PDE5APDE3BPDE3ALMNA | |
| SCHEMBL10742807 | 0.83 | LMNA (0.38) | PDE5APDE3BPDE3ALMNASMN1; SMN2 | |
| SCHEMBL10741674 | 0.83 | PDE5A (0.34) | PDE5APDE3BPDE3A | |
| SCHEMBL10736276 | 0.83 | PDE5A (0.34) | PDE5APDE3BPDE3A | |
| SCHEMBL10739674 | 0.82 | LMNA (0.39) | PDE5APDE3BPDE3APARP1LMNA | |
| SCHEMBL10739601 | 0.82 | PDE2A (0.46) | PDE5APDE3BPDE3APARP1LMNA | |
| SCHEMBL10737760 | 0.81 | PDE5A (0.35) | PDE5APDE3BPDE3APARP1LMNA | |
| SCHEMBL10737627 | 0.80 | PDE5A (0.35) | PDE5APDE3BPDE3ASMN1; SMN2NPSR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-4654344-A | ALSO AFFECT BLOOD PRESSURE AND MYOCARDIAL CONTRACTIONS | MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) | 1987-03-31 | — | — | US | disclosed |
| EP-0093951-B1 | 2-ARYL-TETRAAZAINDENES | MERCK PATENT GmbH (DE) | 1986-10-29 | — | — | EP | disclosed |
| US-4575505-A | Pharmaceutical compositions containing 2-aryltetraazaindenes for treating ulcers or cardiac insufficiency or blood pressure abnormalities | MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) | 1986-03-11 | — | — | US | disclosed |
| US-4477454-A | INDOTROPIC AGENTS | MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) | 1984-10-16 | — | — | US | disclosed |
| EP-0093951-A2 | 2-Aryl-tetraazaindenes | MERCK PATENT GmbH (DE) | 1983-11-16 | — | — | EP | disclosed |